StockData
Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc. (NRIX) income statement

NRIXNasdaqPharmaceutical PreparationsFiscal year ends November 30
Financials through Q3 FY2026, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 13, 2026Score 15/3073% below fair value
$14.10−0.14 (-0.98%)

Close on Nov 18, 2026Market cap $1.54BP/E 6.1Yield 0.00%

See a number that looks wrong?